XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Commitment to Issue Class A Common Stock and Stockholders’ Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Notes Payable
Class A
Class A
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Class A
Common Stock
Class A
Notes Payable
Common Stock
Class B
Additional Paid-in Capital
Additional Paid-in Capital
Notes Payable
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2021                        
Beginning balance at Dec. 31, 2021       $ 0                  
Beginning balance (Accounting Standards Update 2020-06) at Dec. 31, 2021         $ 32,900                
Ending balance (in shares) at Jun. 30, 2022       0                  
Ending balance at Jun. 30, 2022       $ 32,900                  
Beginning balance (in shares) at Dec. 31, 2021           168,693,323   0          
Beginning balance at Dec. 31, 2021 $ 567,654         $ 17   $ 0 $ 3,482,226   $ (6,945) $ (2,907,644)  
Beginning balance (Accounting Standards Update 2020-06) at Dec. 31, 2021   $ (20,265)                     $ (20,265)
Beginning balance (Accounting Standards Update 2016-02) at Dec. 31, 2021   3,393                     3,393
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Issuance of shares (in shares)           68,887,416   64,000,588          
Issuance of shares 0         $ 7   $ 6 (13)        
Stock-based compensation 6,474               6,474        
Exercise of stock options (in shares)           962,736              
Exercise of stock options 2,354               2,354        
Foreign currency translation adjustment 3,684                   3,684    
Net loss (294,792)                     (294,792)  
Ending balance (in shares) at Jun. 30, 2022           238,543,475   64,000,588          
Ending balance at Jun. 30, 2022 268,502         $ 24   $ 6 3,491,041   (3,261) (3,219,308)  
Beginning balance (in shares) at Dec. 31, 2021                        
Beginning balance at Dec. 31, 2021       $ 0                  
Beginning balance (Accounting Standards Update 2020-06) at Dec. 31, 2021         $ 32,900                
Beginning balance (in shares) at Dec. 31, 2021           168,693,323   0          
Beginning balance at Dec. 31, 2021 567,654         $ 17   $ 0 3,482,226   (6,945) (2,907,644)  
Beginning balance (Accounting Standards Update 2020-06) at Dec. 31, 2021   (20,265)                     (20,265)
Beginning balance (Accounting Standards Update 2016-02) at Dec. 31, 2021   $ 3,393                     $ 3,393
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Reclassification of Feb. 28, 2023 stock-based awards liability to equity due to authorized share increase (Note 11) (4,000)                        
Ending balance (in shares) at Dec. 31, 2022           563,346,216   64,000,588          
Ending balance at Dec. 31, 2022 200,992         $ 56   $ 6 3,724,180   3,505 (3,526,755)  
Beginning balance (in shares) at Mar. 31, 2022       0                  
Beginning balance at Mar. 31, 2022       $ 32,900                  
Ending balance (in shares) at Jun. 30, 2022       0                  
Ending balance at Jun. 30, 2022       $ 32,900                  
Beginning balance (in shares) at Mar. 31, 2022           238,197,018   64,000,588          
Beginning balance at Mar. 31, 2022 402,322         $ 24   $ 6 3,487,415   (7,509) (3,077,614)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Issuance of shares (in shares)           145,396              
Stock-based compensation 3,127               3,127        
Exercise of stock options (in shares)           201,061              
Exercise of stock options 499               499        
Foreign currency translation adjustment 4,248                   4,248    
Net loss (141,694)                     (141,694)  
Ending balance (in shares) at Jun. 30, 2022           238,543,475   64,000,588          
Ending balance at Jun. 30, 2022 268,502         $ 24   $ 6 3,491,041   (3,261) (3,219,308)  
Beginning balance (in shares) at Dec. 31, 2022           563,346,216   64,000,588          
Beginning balance at Dec. 31, 2022 200,992         $ 56   $ 6 3,724,180   3,505 (3,526,755)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Conversion of notes payable and accrued interest into Class A Common Stock (Note 9) (in shares)             807,189,395            
Conversion of notes payable and accrued interest into Class A Common Stock (Note 9)     $ 283,109       $ 81     $ 283,028      
Change in classification of warrants from Additional paid-in capital to liability pursuant to the Warrant Exchange (Note 9) (6,811)               (6,811)        
Reclassification of Feb. 28, 2023 earnout shares liability to equity due to authorized share increase (Note 11) 5,014               5,014        
Reclassification of Feb. 28, 2023 stock-based awards liability to equity due to authorized share increase (Note 11) 8,978               8,978        
Reclassification of Feb. 28, 2023 stock-based awards liability to equity due to authorized share increase (Note 11) (2,112)               (2,112)        
Reclassification of stock-based awards from equity to liability on April 21, 2023 due to insufficient authorized shares (Note 11) (2,979)               (2,979)        
Stock-based compensation $ 4,523               4,523        
Exercise of warrants (in shares) 60,395,603         51,128,708              
Exercise of warrants $ 51,276         $ 5     51,271        
Exercise of stock options (in shares)           49,456              
Exercise of stock options 44               44        
Issuance of shares for RSU vesting       $ 0                  
Issuance of shares for RSU vesting (in shares)           2,284,949              
Cancellations (in shares)           (247,340)              
Foreign currency translation adjustment 5,567                   5,567    
Net loss (269,901)                     (269,901)  
Ending balance (in shares) at Jun. 30, 2023           1,423,751,384   64,000,588          
Ending balance at Jun. 30, 2023 277,700         $ 142   $ 6 4,065,136   9,072 (3,796,656)  
Beginning balance (in shares) at Mar. 31, 2023           838,872,039   64,000,588          
Beginning balance at Mar. 31, 2023 255,777         $ 84   $ 6 3,924,465   2,950 (3,671,728)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Conversion of notes payable and accrued interest into Class A Common Stock (Note 9) (in shares)             583,649,776            
Conversion of notes payable and accrued interest into Class A Common Stock (Note 9)     $ 144,928     $ 58       $ 144,870      
Reclassification of Feb. 28, 2023 stock-based awards liability to equity due to authorized share increase (Note 11) (2,112)               (2,112)        
Reclassification of stock-based awards from equity to liability on April 21, 2023 due to insufficient authorized shares (Note 11) (2,979)               (2,979)        
Stock-based compensation 892               892        
Issuance of shares for RSU vesting (in shares)           1,476,909              
Cancellations (in shares)           (247,340)              
Foreign currency translation adjustment 6,122                   6,122    
Net loss (124,928)                     (124,928)  
Ending balance (in shares) at Jun. 30, 2023           1,423,751,384   64,000,588          
Ending balance at Jun. 30, 2023 $ 277,700         $ 142   $ 6 $ 4,065,136   $ 9,072 $ (3,796,656)